A neutral PBM intelligence and procurement platform providing transparency, benchmarking, and decision support for employers, payers, and advisors.
Six analytical tools for evaluating PBM performance, benchmarking pricing, and supporting procurement decisions. All tools are free and require no registration.
Compare pricing against NADAC acquisition costs and market benchmarks for 80+ common medications.
Free ToolScan contract language against a library of 16 commonly problematic clauses with guidance.
Free ToolSide-by-side comparison of 18 PBMs across pricing model, rebates, audit rights, and transparency.
Free ToolModel potential cost differences based on plan size, drug mix, and PBM pricing characteristics.
Free ToolReference database of 16 contract provisions with impact analysis and alternatives.
Free Tool50+ categorized procurement questions with context on relevance and evaluation guidance.
Free ToolCompare medication pricing against NADAC (National Average Drug Acquisition Cost) and typical market rates to understand pricing variance.
Scan contract text against a database of commonly problematic provisions. Identifies language patterns associated with pricing opacity and unfavorable terms.
Comparative analysis of pharmacy benefit managers across key operational and contractual characteristics. Data current as of Q1 2025.
| PBM | Market Share | Pass-Through | 100% Rebates | Audit Rights | Spread Pricing | Owned Rx |
|---|
Model potential cost differences based on typical pricing variance patterns. Estimates are illustrative and based on industry benchmarks.
16 contract provisions commonly associated with pricing opacity, reduced audit capabilities, or unfavorable terms.
Categorized procurement questions for PBM evaluation. Each includes context on relevance and what to look for in responses.
Not Legal or Financial Advice: The information provided on this platform is for general informational and educational purposes only. It does not constitute legal, financial, or professional advice. You should consult with qualified professionals before making any decisions based on the information provided.
No Warranty: While we strive to provide accurate and up-to-date information, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information, tools, or related graphics contained on this platform.
Data Sources: PBM market data is compiled from publicly available sources including Drug Channels Institute reports, FTC publications, SEC filings, and company disclosures. Drug pricing data references CMS NADAC files and published industry benchmarks. Data is subject to change without notice.
Independence: RxPBM.ai is an independent platform and is not affiliated with, endorsed by, or sponsored by any pharmacy benefit manager, pharmaceutical company, or healthcare organization.
Privacy: Contract analysis is performed entirely within your browser. No contract text or sensitive information is transmitted to our servers or stored.
Limitation of Liability: In no event shall RxPBM.ai, BuiltforAI LLC, or its affiliates be liable for any indirect, incidental, special, consequential, or punitive damages arising from your use of this platform.
Last updated: December 2024
Receive notifications on new tools, data updates, and regulatory developments.
By subscribing, you agree to receive periodic emails from RxPBM.ai. You may unsubscribe at any time. We do not share your information with third parties.